https://www.selleckchem.com/products/sc75741.html
1 months in the palliative care group. Patients with higher level of serum Cyfra21-1 had insignificantly shorter survival time compared to those with normal Cyfra21-1 ( = 0.067). TKI therapy and non-TKI therapy provided a better prognosis prediction compared to palliative care. TKI therapy improved prognosis compared to non-TKI therapy. The comprehensive based TKI therapy provided improved OS vs the non-TKI therapy. TKI-based therapy could improve the prognosis and OS for advanced P-ADC. This study recommends the analysis of mutations f
Like
Comment
Share
